Ronghe Gu
NO. 89 Qixin Road
Nanning, 530022, China
Nanning, 530022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Research on the regulation of osteogenic differentiation and mechanotransduction by porous bionic coatings on titanium alloy implant surfaces.
Journal: RSC advances
Published: February 10, 2026
Mendelian randomization identifies multiple immune cell surface markers as potential causal contributors and drug targets in rheumatoid arthritis.
Journal: The Journal of international medical research
Published: January 22, 2026
PRKN-Mediated Ubiquitin-Proteasome Degradation of METTL3 Promotes Cellular Senescence.
Journal: Aging cell
Published: June 25, 2025
The global burden of osteoarthritis hand: lessons from the Global Burden of Disease Study 1990-2021.
The global burden of osteoarthritis hand: lessons from the Global Burden of Disease Study 1990-2021.
Journal: Frontiers in medicine
Published: April 22, 2025
Heme metabolism mediates RANKL-induced osteoclastogenesis via mitochondrial oxidative phosphorylation.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: May 25, 2024
Therapeutic impacts of GNE‑477‑loaded H2O2 stimulus‑responsive dodecanoic acid‑phenylborate ester‑dextran polymeric micelles on osteosarcoma.
Journal: International journal of molecular medicine
Published: December 19, 2023
AM1241 inhibits chondrocyte inflammation and ECM degradation through the Nrf2/HO-1 and NF-κB pathways and alleviates osteoarthritis in mice.
Journal: Molecular medicine (Cambridge, Mass.)
Published: December 12, 2023
Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity.
Journal: Frontiers in pharmacology
Published: September 20, 2023
Global Single-Cell Sequencing Landscape of Adipose Tissue of Different Anatomical Site Origin in Humans.
Journal: Stem cells international
Published: September 14, 2022
Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss.
Journal: Frontiers in pharmacology
Published: February 07, 2022
Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity.
Journal: Frontiers in pharmacology
Published: December 22, 2020
Last Updated: 09/26/2026